Precision Promise (PrP) Bayesian platform trial for metastatic pancreatic cancer (mPDAC): Results of the first experimental arm, SM-88 as second line therapy Meeting Abstract
| Authors: | Oberstein, P. E.; Wang-Gillam, A.; Varghese, A. M.; Ko, A. H.; Hendifar, A. E.; Ocean, A. J.; McGlothlin, A.; Graves, T.; Berry, S. M.; Detry, M. A.; Fitzgerald, M.; Bosse, A.; Moravek, C.; Feehan, K.; Howland, C. M.; Berry, D. A.; Simeone, D. M.; Picozzi, V. J. |
| Abstract Title: | Precision Promise (PrP) Bayesian platform trial for metastatic pancreatic cancer (mPDAC): Results of the first experimental arm, SM-88 as second line therapy |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Keywords: | 281-318-9508; 261-492-3532-2370-7650-2700; 261-492-2769; 281-318-9490; 3282-3301-2586 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500417 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.675 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 675 -- Source: Wos |
